Key statistics
As of last trade United Therapeutics Corp (UTH:STU) traded at 399.00, -9.30% below its 52-week high of 439.90, set on Dec 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 397.10 |
|---|---|
| High | 406.50 |
| Low | 396.80 |
| Bid | 398.40 |
| Offer | 399.20 |
| Previous close | 401.90 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 43.06m |
| Free float | 42.26m |
| P/E (TTM) | 17.93 |
| Market cap | 20.39bn USD |
| EPS (TTM) | 26.41 USD |
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Press releases
- United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
